| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 01/15/2003 | EP1274701A1 Chemical compounds |
| 01/15/2003 | EP1095045B1 Method for producing anellated triazoles and new anellated triazoles and their use |
| 01/15/2003 | EP1023265B1 Azetidinone derivatives for the treatment of hcmv infections |
| 01/15/2003 | CN1391576A Androgen receptor modulator compounds and methods |
| 01/15/2003 | CN1391573A Bicyclic imidazo-3-yl-amine derivatives |
| 01/15/2003 | CN1098854C Imidazothiazoles |
| 01/14/2003 | US6506936 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production |
| 01/14/2003 | US6506773 Hydroxamic and carboxylic acid derivatives |
| 01/14/2003 | US6506769 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 01/14/2003 | US6506768 Tetrahydro γ-carbolines |
| 01/14/2003 | US6506507 Methine compound, material for organic luminescence element, and organic luminescence element using the same |
| 01/09/2003 | WO2003002503A1 Thienothiazine compounds having anti-inflammatory and analgesic activities and their preparation methods and the use there of |
| 01/09/2003 | WO2002059111A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/09/2003 | US20030008894 Antimicrobial quinolones, their compositions and uses |
| 01/09/2003 | US20030008867 Compounds |
| 01/09/2003 | US20030008848 Small molecules useful in the treatment of inflammatory disease |
| 01/08/2003 | EP1272452A2 Process for the preparation of (r)-2-bromo-3-phenyl-propionic acid |
| 01/08/2003 | CN1390222A Imidazole compounds used as phosphodiesterase VII inhibitors |
| 01/07/2003 | US6503897 N-Formylhydroxylamine derivatives; veterinary medicine; grampositive and gramnegative bacteria |
| 01/03/2003 | WO2003000682A1 (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds |
| 01/03/2003 | WO2003000680A1 Diamine derivatives |
| 01/03/2003 | WO2003000657A1 Diamine derivatives |
| 01/03/2003 | WO2002020531A3 Method for producing anellated tetrahydro-[1h]-triazoles |
| 01/03/2003 | CA2450555A1 (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds |
| 01/02/2003 | US20030004351 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 01/02/2003 | US20030004344 Thrombin or factor Xa inhibitors |
| 01/02/2003 | US20030004181 Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions |
| 01/02/2003 | US20030004164 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004161 Anticancer agents; autoimmune diseases |
| 01/02/2003 | EP1270557A1 Ethylenediamine derivatives |
| 01/02/2003 | EP1268489A1 Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-a]pyrimidines as antidepressant agents |
| 01/02/2003 | EP1268488A1 A process for preparing cephalosporin derivatives using new thiazole compound |
| 01/02/2003 | EP1268487A1 Tricyclic protein kinase inhibitors |
| 01/02/2003 | EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/02/2003 | EP1267855A2 Vasopeptidase inhibitors to treat isolated systolic hypertension |
| 01/02/2003 | EP1073648A4 12,13-modified epothilone derivatives |
| 01/02/2003 | EP1073647A4 12,13-cyclopropane epothilone derivatives |
| 01/02/2003 | EP1053246B1 Beta-sheet mimetics and methods relating to the use thereof |
| 12/31/2002 | US6500855 Nitrogen containing aromatic heterocycles with ortho-substituted p1 groups; anticoagulants |
| 12/31/2002 | US6500839 CRF receptor antagonists and methods relating thereto |
| 12/27/2002 | WO2002102809A1 Thiazolotriazole derivatives, intermediates thereof, and herbicides containing the derivatives as the active ingredient |
| 12/27/2002 | WO2002102377A1 Immune response modifiers for the treatment of periodontal disease |
| 12/27/2002 | CA2449754A1 Immune response modifiers for the treatment of periodontal disease |
| 12/26/2002 | US20020198214 Such as (3-(4-(4-fluoro-benzyl)-piperidine-1-carbonyl)-4-methoxy-phenyl)-oxo-acetic acid methyl ester for proinflammation response in multiple sclerosis, inflammatory bowel disease, osteoarthritis, and other arthritic conditions |
| 12/26/2002 | US20020198213 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 12/26/2002 | US20020198190 Tetracyclic 1,2,3,4,5,6- hexahydroazepino-(4,5-b)indole derivatives having a ring connecting position 6 (N-6) and position 7 (C-7); treating or preventing a disease or disorder of the central nervous system in a mammal |
| 12/26/2002 | US20020198178 Viricides for preventing infection by HIV, treating infection by HIV, delaying of the onset of AIDS, or treating AIDS |
| 12/25/2002 | CN1387087A Color coupler for forming dye, silver halide photosensitive material and azomethine dyes compounds |
| 12/25/2002 | CN1097054C Tricyclic pyrazole derivs. and composition |
| 12/25/2002 | CN1097053C 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivs., preparing method and use thereof |
| 12/24/2002 | US6498251 Tetrahydrobenzindole derivatives |
| 12/24/2002 | US6498176 Inhibiting tumor growth via inhibition of tumor-related angiogenesis |
| 12/24/2002 | US6498167 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 12/24/2002 | CA2150812C Catechol diethers as selective pde iv inhibitors |
| 12/19/2002 | WO2002100860A2 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
| 12/19/2002 | WO2002092606A8 Fused imidazolidine derivatives, process for preparation of the same and use thereof |
| 12/19/2002 | WO2002060894A3 Sulfonamide lactam inhibitors of factor xa |
| 12/19/2002 | US20020193360 For enhancing cognition or in the treatment of diseases of cognitive dysfunction including but not limited to Alzheimer's Disease (AD), mild cognitive impairment, age-related cognitive decline, vascular dementia, Parkinson's disease |
| 12/18/2002 | EP1266950A1 Lubricant composition containing a triazine molecular complex compound |
| 12/18/2002 | EP1265904A1 Novel positive allosteric ampa receptor modulators (paarm), method for the production and use thereof as medicaments |
| 12/12/2002 | WO2002098868A1 Epothilone derivatives |
| 12/12/2002 | WO2002064080A3 Matrix metalloproteinase inhibitors |
| 12/12/2002 | US20020188015 Method and composition for rejuvinating cells, tissues organs, hair and nails |
| 12/12/2002 | CA2449077A1 Epothilone derivatives |
| 12/11/2002 | EP1100805B1 Medicine nitrate salts |
| 12/11/2002 | EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors |
| 12/10/2002 | US6492398 Thiazoloindolinone compounds |
| 12/10/2002 | US6492366 Cyano-indole serotonin-reuptake inhibitor compound |
| 12/05/2002 | US20020183327 For use as analgesics |
| 12/05/2002 | US20020183320 For use as analgesics |
| 12/04/2002 | EP1262181A1 Urease inhibitors |
| 12/04/2002 | EP1261731A1 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds |
| 12/04/2002 | EP1261607A1 2,4-disubstituted thiazolyl derivatives |
| 12/04/2002 | EP0907650B1 N- 4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 12/03/2002 | US6489351 Condensed 4,5,6,7-tetrahydrobenzo[C]thiophenes as enhancer for cell differentation induction factor action |
| 12/03/2002 | US6489323 Inhibiting no production from l-arginine, as seen in disease states such as arthritis and systemic hypotension associated with septic and/or toxic shock |
| 12/03/2002 | CA2263500C Malonate derivatives useful as intermediates for producing isoxazolidinadione hypoglycemic agents |
| 12/03/2002 | CA2074933C Thiazole derivatives as active superoxide radical inhibitors |
| 11/28/2002 | WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 11/28/2002 | WO2002094797A1 Oxazin(thi)one compounds used as fungicides |
| 11/28/2002 | WO2002094796A2 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases |
| 11/28/2002 | WO2002094264A1 Ccr4 antagonists |
| 11/28/2002 | CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 11/28/2002 | CA2446141A1 Oxazin(thi)one compounds used as fungicides |
| 11/27/2002 | EP1259512A1 Pteridine compounds for the treatment of psoriasis |
| 11/27/2002 | EP1259508A1 Novel biarylcarboxamides |
| 11/27/2002 | EP1259489A1 Aryl fused azapolycyclic compounds |
| 11/27/2002 | CN1382143A Inhibitors of alpha L beta 2 mediated cell adhesion |
| 11/27/2002 | CN1381456A Pyrimidine-4-keto compound, its preparation method and medicine composition containing them |
| 11/27/2002 | CN1381455A Method for synthe sizing (3aS)-5, 5-dioxo-2, 3, 3a, 4-tetrahydric-1H-pyrrolo [2,1-c] [1,2,4] benzodiazine |
| 11/26/2002 | US6486328 Substituted 2-[-6-benzyl-5-oxo-3-phenyl-(3s,7s, 7aR)-perhydroimidazol[1,5-c][1,3]thiazol-7yl] compounds |
| 11/26/2002 | US6486315 Recrystallization processes |
| 11/26/2002 | US6486187 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 11/21/2002 | WO2002092606A1 Fused imidazolidine derivatives, process for preparation of the same and use thereof |
| 11/21/2002 | WO2002092595A1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 11/21/2002 | WO2002092083A1 7,8-fused 4$i(h)-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 11/21/2002 | WO2002092076A1 Substituted coumarins and quinolines as caspases activators |
| 11/21/2002 | WO2002012250B1 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 11/21/2002 | US20020173524 Modulation of CCR4 function |
| 11/21/2002 | US20020173503 Substituted pyridoindoles as serotonin agonists and antagonists |